Inventors:
Mark A. Goldberg - Boston MA
William C. Faquin - Boston MA
Assignee:
Brigham and Women's Hospital - Boston MA
International Classification:
A61K 4505, C07K 1300
Abstract:
The invention is directed to the administration of Interleukin 6 for the purpose of enhancing endogenous erythropoietin levels in vitro and in vivo. The invention further encompasses methods of treatment of disorders characterized by, or including, erythropoietin deficiency. Such disorders include the anemias of chronic inflammation, renal failure, AIDS, and malignancy.